RTEL1 helps cells protect chromosome ends (telomeres) and keep DNA from tangling during cell division. This gene plays an important role in keeping telomeres the right length and supporting DNA repair. When RTEL1 does not work well, telomeres can become too short or unstable, which may lead to low blood counts, immune problems, or lung scarring (pulmonary fibrosis). Certain harmful variants in the RTEL1 gene can cause inherited telomere disorders such as dyskeratosis congenita and can increase the chance of some cancers, while many variants have little effect.
What is a gene?
Genes are stretches of DNA that store instructions your cells use to make molecules or guide how the body works. Many genes carry the recipe for proteins, which are the parts of cells that do much of the day-to-day work. Others are more involved in regulating when certain activities happen, where they occur, and how strongly they are carried out. As a group, genes affect how the body grows and operates, and they can also shape how you react to food, stress, or medications. For a deeper look at this topic, you can find more information in the LearnHub.
Overview
RTEL1Gene function
What if the gene works
RTEL1 helps keep chromosome ends (telomeres) stable when cells divide. Its protein unwinds DNA and supports DNA repair, which helps prevent harmful breaks and cell stress. This steady telomere upkeep supports long-term tissue health.
Risk
What if the gene does not work
When the RTEL1 gene does not work well, telomeres can shorten too fast, which may lead to bone marrow failure (low blood counts) and lung fibrosis. DNA changes range from milder to severe, influencing onset, severity, and affected organs.
Treatment
What does that mean for your treatment
RTEL1 variants can influence how aggressively clinicians use chemotherapy, radiation, or bone marrow transplant conditioning, since very short telomeres can raise treatment toxicity. Care may favor reduced-intensity transplant regimens and close monitoring; no compensating-gene therapy is established.
Conditions associated with RTEL1
Gene function
What if the gene works
Every day, your cells copy and organize their DNA so tissues can grow, renew, and function normally. The RTEL1 gene supports this steady work by helping chromosomes stay well-protected and easier to copy. When RTEL1 is working properly, cell division tends to be more orderly because DNA is handled in a controlled, consistent way.
RTEL1 helps cells maintain telomeres, the protective caps at the ends of chromosomes. This RTEL1 gene function in telomere maintenance supports orderly chromosome copying during cell division.
Its protein helps unwind DNA when it forms tight loops or knots during routine cell activity. By keeping the DNA strand easier to read, RTEL1 supports smooth DNA copying as cells grow and renew.
RTEL1 works with your cells’ repair tools to resolve certain kinds of DNA damage from normal wear and tear. This helps keep genetic information consistent from one cell generation to the next.
What is a variant?
A genetic variant refers to a minor difference in the DNA code within a gene. These differences are widespread and help explain normal variation among people, including traits like appearance, how the body processes nutrients and medications, or how someone responds to things in the environment. A large number of variants do not cause any clear changes and are part of typical genetic diversity. In certain situations, though, a variant can meaningfully affect how a gene works and may contribute to, or directly lead to, a genetic condition.
Genetic variants
What if the gene does not work
Changes in the RTEL1 gene can weaken the body’s ability to protect chromosome ends (telomeres, the protective caps on DNA) and to cope with certain types of DNA damage. Depending on the variant, an RTEL1 gene mutation may slightly reduce function or severely disrupt it, which can influence how early symptoms appear and which features show up. Milder variants are often linked to adult-onset lung scarring (pulmonary fibrosis), while more disruptive mutations can contribute to very short telomeres, low blood counts, and related telomere disorders.
How variants are linked to conditions
Some people with variants in the RTEL1 gene develop a group of inherited conditions often called telomere biology disorders, which can include dyskeratosis congenita and Hoyeraal Hreidarsson syndrome. Pathogenic RTEL1 variants are also a well-established cause of some familial forms of pulmonary fibrosis, so RTEL1 gene pulmonary fibrosis is a recognized clinical link. Depending on the variant, related findings can include bone marrow failure and low blood counts. In large population studies, certain common RTEL1 variants are associated with a higher risk of glioma, but this kind of association does not guarantee disease.
A variant is not necessarily a diagnosis
Differences in DNA, often called genetic variants, are expected in humans and occur frequently across the population. The majority of these variants do not directly affect health and simply reflect normal human variation. With many genes, having a variant that has been linked to a condition usually suggests a possible connection rather than a certain diagnosis, particularly when several genes and environmental influences contribute. In contrast, there are situations where one well-studied variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
With a disease-causing change in the RTEL1 gene, the chance of telomere-related health problems is mostly set by the variant, but the timing and severity can still vary. Things that can make lung scarring or low blood counts show up sooner or get worse include smoking, some chemotherapy or radiation treatments, and long-term exposure to heavy dusts or fumes. Regular checkups to spot early changes help prevent complications.
Inheritance of RTEL1 variants
Changes in the RTEL1 gene can be passed down in families, and the RTEL1 gene inheritance pattern can be either autosomal dominant or autosomal recessive, depending on the specific change and condition. In autosomal dominant inheritance, inheriting one changed copy from either parent may be enough to raise the chance of related health problems. In autosomal recessive inheritance, a child typically needs two changed copies, one from each parent, while parents may be unaffected carriers.
What does my RTEL1 result mean for my family?
Seek medical advice if a change in the RTEL1 gene has been found in you or a close relative, especially if your family has early or repeated lung scarring, low blood counts, or bone marrow failure. A genetics or lung specialist can explain which relatives may need checkups and what to watch for. Get prompt care for worsening shortness of breath, unusual bruising or bleeding, or frequent infections.
Genetic information
Genetic testing
How you find out about variants
RTEL1 genetic testing can identify changes in the RTEL1 gene using a blood sample or saliva. A lab reads the gene’s DNA sequence, often as part of a larger panel or whole exome sequencing, and compares it with typical reference sequences. Your report may describe a variant as benign, uncertain, or pathogenic, which guides what steps come next.
When should I consider getting a genetic test?
Consider a genetic test for the RTEL1 gene if you or close relatives have unexplained lung scarring, repeated very low blood counts, or a mix of early-onset problems affecting the lungs, blood, skin, or nails. Testing can also help when a doctor finds unusually short telomeres, the protective ends of DNA. Results may guide screening and family planning.
A genetic result is only one part of your health story
Genetic results can be very informative, but what they can explain varies based on the condition and the specific type of variant. Your health over time is shaped by many factors, including lifestyle, environment, age, and medical history. With some conditions, particularly those influenced by many genes, genetic information provides helpful background rather than a definite prediction and makes the most sense when considered with other parts of care. In other situations, a genetic finding can give a straightforward explanation. For topics like how someone responds to medications, genetic results can also help frame personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic differences can affect how people respond to medicines, and changes in the RTEL1 gene are not commonly used to predict how you will process most drugs. Even with the same dose, one person may break a medicine down faster or slower, which can change how well it works or how likely side effects are. Genes can also influence how sensitive certain tissues are to treatment, which helps explain why responses vary from person to person. Medication response is shaped by genetics along with age, other health conditions, and other medicines you take.
What is Pharmacogenetics?
Pharmacogenetics focuses on how inherited genetic differences can affect the way medications work. It examines links between specific genes and specific drugs to clarify why the same treatment can have different effects in different people. With many medicines, your genes may influence how potent a drug feels or how your body breaks it down. This information can support more informed, more personalized choices about treatment. More detail on this subject is available in the LearnHub.
Drugs influenced by the RTEL1 gene
When should I seek medical advice?
Seek medical advice if you or a family member has unexplained scarring of the lungs with ongoing shortness of breath, very low blood counts (easy bruising, frequent infections, unusual tiredness), or several relatives with these problems, especially at younger ages. People with an RTEL1 gene change should also check in before treatments like chemotherapy, radiation, or a stem cell transplant, because care plans may need adjustment.
History
RTEL1 entered genetics research in the early 2000s, when scientists studying telomeres (the protective caps at the ends of chromosomes) identified it as an important factor in keeping chromosome ends stable. With each decade, genetic studies refined the picture. In the years that followed, changes in the RTEL1 gene were reported in families with inherited telomere related disorders, including forms of dyskeratosis congenita and Hoyeraal Hreidarsson syndrome. Around the same time, large population studies linked common RTEL1 gene variants to a higher chance of developing glioma, a type of brain tumor, helping bring the gene into broader cancer genetics research. More recently, RTEL1 has become part of the clinical conversation for some people and families affected by pulmonary fibrosis, especially when short telomeres are suspected.